White Cell Ratios as Markers of Delirium and Outcome in Acute Ischemic Stroke.
NCT ID: NCT03944694
Last Updated: 2019-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1001 participants
OBSERVATIONAL
2015-06-30
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers in Cerebrospinal Fluid in Critical Care Patients With Delirium
NCT02948374
Education for Recognition and Management of Delirium
NCT03642249
DELirium, Incidence, preVEntion and pRogression During Acute Intensive Neurological -Neurosurgical Rehabilitation
NCT07070310
Effect of Dexmedetomidine on Postoperative Delirium Inflammasome Activation Inhibition
NCT03588988
Nurses' Knowledge, Barriers and Practices in the Assessment of Delirium in the Intensive Care Unit
NCT05384964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Delirious
Patients were delirious if CAM-ICU was positive within 24 hours from admission due to acute ischemic stroke.
Delirium assessment.
Full blood count analysis.
Non-delirious
Patients were delirious if CAM-ICU was negative within 24 hours from admission due to acute ischemic stroke.
Delirium assessment.
Full blood count analysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delirium assessment.
Full blood count analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* acute ischemic stroke
Exclusion Criteria
* incomplete laboratory testing
* no data regarding follow-up
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pomeranian Medical University Szczecin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katarzyna Kotfis
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Iwona Rotter, MD, PhD
Role: STUDY_CHAIR
Pomeranian Medical University Szczecin
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0012/84/03/19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.